In clinical studies for the lead indication of multiple sclerosis (MS), Revimmune improves function in most patients and stops progression in over 90% of cases refractory to standard therapies.
Read More: Revimmune Uses An Approved Drug In A New Patent-Pending Method to Eliminate Autoimmunity